Further, S-1 also has efficacy against squamous cell carcinomas including head and neck, oral, esophagus and thymus [9–11], suggesting S-1 is effective on both squamous carcinomas and adenocarcinomas. This evidence concerns the gene PSMD1 and squamous cell carcinoma.